Log in  First Connection?

Skin Barrier ScienceArchives

Focused update: Guidelines of care for the management of atopic dermatitis in adults

 Published on 08/12/2025 |  Original article (Full-text)  | Davis, Dawn M.R. et al. | Journal of the American Academy of Dermatology 2025; 93(3): 745.e1-745.e7

In 2023 and 2024, the American Academy of Dermatology published guidelines on the use of topical and systemic therapies for the management of atopic dermatitis (AD) in adults. Since the publication of these guidelines, several novel therapies have emerged to treat AD. To update previous guidelines on...

UDP-glucose ceramide glucosyltransferase promotes radioresistance via membrane reorganization to maintain redox balance in glioblastoma

 Published on 01/12/2025 |  Original article (Full-text)  | Lee Haksoo et al. | British Journal of Cancer 2025; 133(11): 1720-32

Glioblastoma (GBM) is a highly aggressive and lethal brain tumor characterized by inevitable recurrence and resistance to standard therapies such as radiotherapy and temozolomide (TMZ) [1, 2–3]. Even after maximal surgical resection and chemoradiation, GBM tumors often relapse within the irradiated...

Anterior segment optical coherence tomography study of the cornea and tear film after systemic isotretinoin treatment in acne vulgaris

 Published on 24/11/2025 |  Original article (Full-text)  | El-Din Mahmoud Mohamed Salah et al. | BMC Ophthalmology 2025; 25(1): 651

Acne vulgaris (AV) is a common dermatological skin disorder. When other treatments for severe cystic AV have failed, isotretinoin (13-cis-retinoic acid) is preferred. Isotretinoin is a first-generation nonaromatic b-carotene retinoid (provitamin A) [1]. Oral isotretinoin results in long-term acne remission...

The mediterranean diet and acne vulgaris: a systematic review and meta-analysis

 Published on 17/11/2025 |  Original article (Full-text)  | Taha Sari et al. | Nutrition & Metabolism 2025; 22(1): 132

Acne vulgaris is a chronic skin condition of the pilosebaceous unit with a multifactorial and intricate pathophysiology that includes increased sebum production, androgenic hormonal effects, follicular hyperkeratinization, and bacterial hyperproliferation [1, 2–3]. Acne lesions may range from mild,...

Sphingolipids in Gaucher disease: a systematic review

 Published on 10/11/2025 |  Original article (Full-text)  | Lake Ashleigh et al. | Orphanet Journal of Rare Diseases 2025; 20(1): 563

Given that the product of glucosylceramide (GlcCer) catabolism is ceramide, it is reasonable to assume that cells will produce less ceramide in Gaucher disease (GD), as GlcCer catabolism is impaired by defective acid beta-glucocerebrosidase (GCase) activity. However, ceramide is also generated from the...